Clearside Biomedical Inc. Daily Stock Analysis

Daily Stock Analysis, CLSD, Clearside Biomedical Inc, priceseries

Clearside Biomedical Inc. Daily Stock Analysis
Stock Information
Open
1.39
Close
1.36
High
1.42
Low
1.35
Previous Close
1.39
Daily Price Gain
-0.03
YTD High
2.95
YTD High Date
Jan 3, 2022
YTD Low
1.33
YTD Low Date
Feb 24, 2022
YTD Price Change
-1.52
YTD Gain
-52.78%
52 Week High
7.73
52 Week High Date
Aug 30, 2021
52 Week Low
1.33
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-1.59
52 Week Gain
-53.90%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 24. 2017
8.06
Feb 28. 2017
8.55
2 Trading Days
6.14%
Link
LONG
Jun 16. 2017
7.82
Jun 30. 2017
9.12
10 Trading Days
16.58%
Link
LONG
Feb 26. 2018
6.23
Mar 22. 2018
11.79
18 Trading Days
89.33%
Link
LONG
Jan 30. 2019
1.17
Feb 19. 2019
1.29
13 Trading Days
10.58%
Link
LONG
Oct 28. 2019
0.97
Nov 7. 2019
1.11
8 Trading Days
14.01%
Link
LONG
Nov 22. 2019
1.15
Jan 2. 2020
2.66
26 Trading Days
131.13%
Link
LONG
Jan 14. 2020
2.40
Feb 3. 2020
3.20
13 Trading Days
33.18%
Link
LONG
Apr 8. 2020
1.72
Apr 21. 2020
1.89
8 Trading Days
10.03%
Link
LONG
Jun 4. 2020
2.22
Jun 5. 2020
2.38
1 Trading Days
7.43%
Link
LONG
Dec 30. 2020
2.32
Jan 21. 2021
3.59
14 Trading Days
54.89%
Link
LONG
Feb 19. 2021
3.85
Feb 22. 2021
4.05
1 Trading Days
5.19%
Link
LONG
Jun 4. 2021
2.89
Jul 14. 2021
5.38
27 Trading Days
86.16%
Link
LONG
Aug 20. 2021
5.65
Sep 3. 2021
6.65
10 Trading Days
17.67%
Link
Company Information
Stock Symbol
CLSD
Exchange
NasdaqGM
Company URL
http://www.clearsidebio.com
Company Phone
678-270-3631
CEO
Daniel H. White
Headquarters
-
Business Address
900 NORTH POINT PARKWAY, SUITE 200, ALPHARETTA, GEORGIA 30005
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001539029
About

Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which develops drug therapies to treat chronic, blinding diseases of the eye, with a particular emphasis on diseases affecting the choroid and retina. The company was founded by Samirkumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry Edelhauser in May 2011 and is headquartered in Alpharetta, GA.

Description

Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading